Title : Activation of the Tumor Suppressor PP2A Emerges as a Potential Therapeutic Strategy for Treating Prostate Cancer.

Pub. Date : 2015 May 27

PMID : 26023836






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We treated PC-3 and LNCaP cell lines with the PP2A activators forskolin and FTY720 alone or combined with the PP2A inhibitor okadaic acid. Fingolimod Hydrochloride protein phosphatase 2 phosphatase activator Homo sapiens
2 Interestingly, both forskolin and FTY720 dephosphorylated and activated PP2A, impairing proliferation and prostasphere formation and inducing changes in AKT and ERK phosphorylation. Fingolimod Hydrochloride protein phosphatase 2 phosphatase activator Homo sapiens
3 Treatment with okadaic acid impaired PP2A activation thus demonstrating the antitumoral PP2A-dependent mechanism of action of both forskolin and FTY720. Fingolimod Hydrochloride protein phosphatase 2 phosphatase activator Homo sapiens
4 Treatment with okadaic acid impaired PP2A activation thus demonstrating the antitumoral PP2A-dependent mechanism of action of both forskolin and FTY720. Fingolimod Hydrochloride protein phosphatase 2 phosphatase activator Homo sapiens